Furthermore, studies have shown that protein kinase A (PKA) directly phosphorylates a specific site of NLRP3 to inactivate it and inhibit pyroptosis, and some patients with NOMID have abnormal NLRP3 activation and pyroptosis due to mutations at this site [113]. This evidence concerns the gene NLRP3 and CINCA syndrome.